A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)

Clinical trial NCT01937871 · COMPLETED

Trial details

NCT number: NCT01937871
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostate Hyperplasia Erectile Dysfunction

Start date: 2013-09-01
Primary completion: 2015-12-01
Enrollment: 909

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.